• Most Popular
  • Most Shared

UPDATE 1-Roche's RoActemra gets positive opinion in Europe

Fri Nov 21, 2008 8:47am EST

Stocks

   

(Adds details)

ZURICH, Nov 21 (Reuters) - Swiss drugmaker Roche Holding AG (ROG.VX) said on Friday its rheumatoid arthritis drug RoActemra had received a positive opinion from the European Committee on Human Medicinal Products (CHMP).

The EU had given RoActemra, which is known as Actemra outside of the EU, a positive recommendation for the treatment of adult patients with moderate to severe rheumatoid arthritis when combined with methotrexate, Roche said.

Recommendations for marketing approval by the CHMP are usually endorsed by the European Commission within a couple of months.

By 1335 GMT, shares in the group had fallen 4.5 percent to 149.20 Swiss francs, roughly in line with a 4 percent drop in the European pharmaceuticals sector .SXDP. (Reporting by Katie Reid; Editing by David Holmes)



More from Reuters

Photo

U.S. probing if al Qaeda linked to airplane incident

WASHINGTON (Reuters) - The Obama administration said on Sunday it was investigating whether al Qaeda was involved in a Christmas Day attempt to blow up a passenger jet and sought to head off Republican attacks over its anti-terrorism measures. | Video

» More Top News
A Delta Airbus 330 airliner sits on a runway at Detroit Metropolitan Airport in Romulus, Michigan in this video grab made December 25, 2009. Credit: REUTERS/WDIV TV/Handout

The battle in mid-air

The attraction of bombing airliners means the aviation industry has to be constantly vigilant in its fight against attackers.  Full Article 

U.S.
A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
Political Risk in 2010:

Don't say we didn't warn you

With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article 

Global Markets